AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASCERTAI

Project: Research project

Project Details

Description

AN OPEN-LABEL, SINGLE-ARM, MULTICENTER STUDY TO ASCERTAIN THE OPTIMAL STARTING DOSE OF MIRCERA?? GIVEN SUBCUTANEOUSLY FOR THE MAINTENANCE TREATMENT OF ANEMIA IN PEDIATRIC PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS OR NOT YET ON DIALYSIS (NH19708)
StatusActive
Effective start/end date2/1/181/30/21

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.